Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

WHAT'S NEW

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, May 6 2026 9:05 AM

Full Issue

While Courts Hash Out Mifepristone Case, Providers Eye Misoprostol For Abortion Care

If the Supreme Court rules that mifepristone can't be prescribed via telehealth or dispensed by mail, providers say, misoprostol alone has been found to be a safe and effective method for ending pregnancies. Some countries already rely on misoprostol for abortion care.

NBC News: If The Abortion Pill Mifepristone Can't Be Mailed, Providers Have A Plan

If people can't get mifepristone by mail, what are their options? Some abortion providers say they would send misoprostol, the other medication in the two-pill regimen, on its own. (Bendix, 5/5)

NPR: Medication Abortion Works With Misoprostol Only. Here's How 

Misoprostol alone can be used effectively for abortions — and is commonly prescribed in some countries. A grassroots effort among women in Brazil, Argentina and other South American countries in the late 1980s and early 1990s spread word that the medicine originally on the market as an ulcer treatment could be used to end unwanted pregnancies. "This regimen is still incredibly safe and effective," says Dr. Kristyn Brandi, a New Jersey family planning specialist and spokesperson for the American College of Obstetricians and Gynecologists. (Gordon, Simmons-Duffin and Webber, 5/4)

More abortion developments —

The Washington Post: Mifepristone Legal Battle Returns Abortion To Political Spotlight 

Democrats with presidential aspirations are raising alarms while congressional candidates in competitive districts have stayed relatively quiet, a sign that the party is still figuring out how to react. Advocates view the legal scuffle over the pill as a fresh opening for Democrats to take abortion off the back burner and capitalize on the issue as they look to win back majorities in Congress. “Reproductive freedom is not safe,” said Mini Timmaraju, president of the national abortion rights group Reproductive Freedom for All. “And moments like this are opportunities to continue to drill that down.” (Somasundaram and Roubein, 5/5)

Roll Call: Cassidy Calls For Expedited Abortion Pill Review As Primary Nears 

Louisiana Sen. Bill Cassidy, at risk of further distancing himself from President Donald Trump as his primary election draws closer, says the administration isn’t doing enough to restrict access to abortion pills. Cassidy, one of the few remaining Republicans in Congress who voted to convict Trump at his impeachment trial after the Jan. 6, 2021, attack on the Capitol, on Tuesday accused the administration of moving too slowly in reviewing the safety of the abortion medication mifepristone. (Cohen, 5/5)

The CT Mirror: CT Looks To 'Shield' Reproductive Care Amid Mifepristone Uncertainty

A legal battle over medication abortion cast uncertainty in recent days over patients’ ability to access it. Connecticut elected officials and advocates gathered Tuesday morning to decry the “chaos” and encourage — with less than 48 hours to go in the legislative session — the strengthening of state laws that protect reproductive care providers. (Golvala, 5/5)

Missouri Independent: Missouri Senate Republicans Drop Lawsuits Over Medication Abortions From ‘Born-Alive’ Bill 

Missouri Senate Democrats secured a victory Tuesday evening in a deal with Republicans to ax provisions in an anti-abortion a bill that sought to open the door for lawsuits against anyone involved in an illegal abortion. The “Born-Alive Abortion Survivors Protection Act” is a top priority of anti-abortion lawmakers as the legislative session nears a close and primary campaign season approaches. (Spoerre, 5/6)

NPR: Wyoming Lawmakers Use Pro-Natalist Arguments To Justify Proposed New Partial Abortion Ban

Wyoming lawmakers say tight new restrictions on abortion are needed to grow the state's population. Demographers and others say economic conditions are more to blame for an exodus of young people. (Merzbach, 5/5)

Also —

The Guardian: Florida Baby ‘Born Twice’ After Elaborate Surgery Involving Partial Delivery

A Florida infant is said to have been born twice after undergoing what was an innovative, likely life-saving surgery that involved a partial delivery weeks before his mother then gave birth to him. Cassian Joubert’s remarkable story was recently first told publicly by his mother and father – Keishera and Greg Joubert – in a 1 May video published on social media by the Orlando Health Women’s Institute, which employs the surgeon that led the baby boy’s prenatal operation. (Vargas, 5/6)

STLPR: One In Four Missourians Report Barriers To Preferred Birth Control, Survey Finds 

One in four Missourians say they’ve run into obstacles obtaining birth control, according to a new survey of about 1,000 people from the Missouri Foundation for Health. (Fentem, 5/6)

CNN: What To Know About A Viral Menopause Trend 

A viral trend claims that a combination of common over-the-counter medications, specifically an allergy drug and an acid reducer, can ease symptoms of perimenopause and menopause. (Hetter, 5/5)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF